Evidence map›Paper›PMID 29921296›Full record

ReviewWorld journal of surgical oncology2018

Acquired factor XII deficiency following transanal excision of rectal lesion by transanal minimally invasive surgery (TAMIS): a case report and literature review.

Maria Rita Cozzi, Andrea Lauretta, Roberto Vettori, Agostino Steffan

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in World journal of surgical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Maria Rita CozziDepartment of Immunopathology and Cancer Biomarkers, CRO National Cancer Institute, I.R.C.C.S, via Gallini, 2, 33080, Aviano, Italy. mrcozzi@cro.it.ORCID http://orcid.org/0000-0001-6841-2632
Andrea LaurettaDepartment of Surgical Oncology, CRO National Cancer Institute, I.R.C.C.S, via Gallini, 2, 33080, Aviano, Italy.
Roberto VettoriDepartment of Immunopathology and Cancer Biomarkers, CRO National Cancer Institute, I.R.C.C.S, via Gallini, 2, 33080, Aviano, Italy.
Agostino SteffanDepartment of Immunopathology and Cancer Biomarkers, CRO National Cancer Institute, I.R.C.C.S, via Gallini, 2, 33080, Aviano, Italy.
Centro di Riferimento Oncologico · ITNational Cancer Institute · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLocal excision (LE) is currently one of the most effective methods used in cases of large benign polyps, not suitable for endoscopic treatment, or early-stage neoplasms. LE is also alternative to anterior rectal resection in selected patients suffering from major comorbidities and limits for major abdominal procedure. Furthermore, LE results in less pain, reduced impact on bowel function, shorter duration of hospital stay, and lower rates of morbidity, mortality and stoma creation. In particular, early data on transanal minimally invasive surgery (TAMIS) are promising, but they come from single centre case series related to small groups of patients and more data are needed to draw a final conclusion on the safety of this novel approach for transanal resection. CASE PRESENTATION: A 62-year-old woman, following a positive faecal occult blood test and with unremarkable medical history, was admitted to hospital for excision of a large flat neoplastic lesion. Endoscopic biopsy demonstrated a tubular adenoma with high-grade dysplasia and was decided to proceed with surgical excision by TAMIS. After surgery, short-term outcomes revealed prolonged activated partial thromboplastin time, undetectable factor XII activity, fever, and partial dehiscence of rectal wall defect suture. Cross-mixing studies of patient plasma show no correction in either the immediate or incubated activated partial thromboplastin time, indicating the presence of an acquired factor XII inhibitor. Activated partial thromboplastin time and factor XII improved in the following weeks without any specific therapy in addition to antibiotic therapy.

conclusionThis is the first report in which acquired inhibitor of coagulation factor XII is associated with a specific surgical procedure. This case has shown how trans-anal excision of rectal lesions, even when performed by minimally invasive means such as in case of TAMIS, is not free of complications. We consider the acute infection, resulting from early dehiscence of the suture, the trigger in an abnormal immune response, and inhibitor development.

Indexed as

Adenomatous PolypsAnal CanalBacterial TranslocationFactor XIIFactor XII DeficiencyFemaleHeparin, Low-Molecular-WeightHumansMiddle AgedMinimally Invasive Surgical ProceduresPartial Thromboplastin TimePrognosisRectal NeoplasmsSurgical Wound DehiscenceTransanal Endoscopic SurgeryFactor XIIHeparin, Low-Molecular-WeightAcquired factor XII deficiencyTransanal endoscopic surgeryTransanal minimally invasive surgery (TAMIS)

Identifiers

PMID29921296
PMCPMC6011201
OpenAlexW2809122617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.